---
title: Medication Dosing and Timing for rTKA Anesthesia
version: 1.0
last-updated: 2025-12-07
---

# Medication Dosing and Timing for rTKA Anesthesia

## 1. Preoperative Medications
- **Acetaminophen 1 g PO** — give 30–60 min pre-op; peak effect 45–60 min
- **Celecoxib 400 mg PO** — give 1–2 hours pre-op; 24-h coverage
- **Dexamethasone 8–10 mg IV** — give after IV placement; onset 10–15 min
- **Scopolamine 1.5 mg patch** — "night before" OR ≥2 hours pre-op

## 2. Induction Agents (timing, onset, duration)
- **Midazolam 1–2 mg IV** — anxiolysis/amnesia; onset 1–3 min; duration 30–60 min
- **Propofol 1.5–2 mg/kg IV** — onset 30–45 sec; duration 5–10 min
- **Ketamine 0.3–0.5 mg/kg IV** — onset <30 sec; duration 10–20 min
- **Dexmedetomidine 0.5 mcg/kg IV over 10–20 min** — loading dose (optional)
- **Magnesium sulfate 30–50 mg/kg IV over 15–20 min** — NMDA antagonism
- **Lidocaine 1–1.5 mg/kg IV** (optional, block-free pathway)
- **Rocuronium 0.6–1.0 mg/kg IV** — onset 45–60 sec

## 3. Maintenance Infusions (with titration notes)
- **Sevoflurane 0.8–1.2 MAC** OR **Propofol 75–150 mcg/kg/min** (TIVA)
- **Dexmedetomidine 0.2–0.7 mcg/kg/hr** — titrate to HR/BP
- **Ketamine 0.1–0.25 mg/kg/hr** — higher end for block-free pathway
- **Lidocaine 1–2 mg/kg/hr** (optional, block-free pathway; max 300 mg total)

## 4. Emergence Timing
- Stop dexmedetomidine **10–15 minutes** before extubation
- **Ondansetron 4 mg IV** — antiemetic prophylaxis
- Reverse NMBD with **sugammadex 2 mg/kg** PRN
- Expect wake-up in **5–10 minutes** after stopping anesthetic

## 5. PACU Rescue Options
- **Ketamine 0.1–0.15 mg/kg IV** q10–15 min, max 3 doses
- **Hydromorphone 0.2 mg IV** q10 min PRN (opioid pathway patients)

## 6. Regional Blocks (if applicable)
- **ACB:** 20–30 mL ropivacaine 0.2–0.25%
- **IPACK:** 20 mL ropivacaine 0.2–0.25%
- Perform after anticoagulation clearance per ASRA 2024 guidelines

---

## Notes
- All doses assume normal renal/hepatic function and average adult weight (70 kg)
- Adjust for frail elderly, cardiac disease, or renal impairment per safety guidelines
- Midazolam and sevoflurane are standard practice and do not compromise OFIA principles
